Serum leptin level in rheumatoid arthritis and its relationship with disease activity

Main Article Content

Zena M Al-Youzbaky
Zainalabideen A Abdulla

Abstract

Objectives: To evaluate serum leptin levels in rheumatoid arthritis (RA) patients and to investigate its correlation with parameters of disease activity including DAS-28, C- reactive protein (CRP) and ESR.
Materials and Methods: This study included 60 rheumatoid arthritis  patients attended Ibn-Sina and Al-Salam Teaching Hospitals during the period from December 2013 to June 2014. The study also included 30 apparently healthy individuals as a control group who were age, gender, and merely body mass index matched to rheumatoid arthritis patients. Full clinical assessment of the patients was conducted by consultant rheumatologists/physicians. A Questionnaire Form was completed and DAS-28 was calculated. Five milliliters of blood were collected from patients and controls, then centrifuged and  the serum was separated and frozen as aliquots at -20 co until use. The sera were tested by enzyme linked immune-sorbent assay ( ELISA) for leptin.
Results: Serum leptin levels in RA patients in comparison to the control group were within normal range. Its value varied ranging between 0.7 to 7.5 ng/ml (in patients), and mean ± stander deviation in RA patients 2.1 ± 4.2  and in controls 3.13 ± 2.30. In RA patients, there was no correlations between serum leptin levels and DAS-28, CRP, ESR. Serum leptin levels positively correlated with body mass index (BMI) in both patient and control groups.
Conclusions: Circulating leptin level does not seem to reflect disease activity in rheumatoid arthritis since there is no correlation between  its serum levels and parameters of disease activity namely DAS -28, CRP, ESR.

Article Details

How to Cite
Zena M Al-Youzbaky, & Zainalabideen A Abdulla. (2023). Serum leptin level in rheumatoid arthritis and its relationship with disease activity. Tikrit Journal of Pure Science, 20(2), 49–53. https://doi.org/10.25130/tjps.v20i2.1158
Section
Articles

References

1. Choy, E. Understanding the dynamics: pathways involved in pathogenesis of rheumatoid arthritis. Oxford Journal of Rheumatology. 2012;51: v3-v11. 2. Jawaheer, D, Lum, R, Gregersen, P, Criswell, L. Influence of sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheumatism. 2006; 54(10): 3087-94.

3. Yoshino, T, Kusunoki, N, Tanaka, N, Kaneko, K, Kusunoki, Y, et al. Elevated Serum Levels of Resistin, Leptin, and Adiponectin are Associated with C-reactive Protein and also Other Clinical Conditions in Rheumatoid Arthritis. Internal Medicine. 2011; 50: 269-275. 4. Wozniak, SE, Gee, LL, Wachtel, MS, Frezza, EE. Adipose tissue: the new endocrine organ? A review article. Digestive Diseases and Sciences. 2009; 54:1847–1856. 5. Lee, S, Park, M.C, Park, Y.P, Lee, S.K. Measurement of serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int.2007; 27 (6) :537–540 6. Targojska-Stdpniak, B, Majdan, M, Dryglewska, M. Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int. 2008; 28 :585–591 7. Popa, C, Nete, M.G, Radstake, T.R, Riel, P.L. Van Barrera, P, Meer, J.W. van der. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005;64:1195–1198

8. Hizmetli, S, Kisa, M, Gokalp, N, Bakici, M.Z. Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis?.

Rheumatol Int. 2007;27(4): 335–338 9. Tokarczyk-Knapik, MA, Nowicki Wyroslak, J. The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn. 2002;108:761–767 10. Bokarewa, M , Bokarew, D, Hultgren, O, Tarkowski, A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2003; 62: 952–956 11. Prevoo, ML et al. http//www.Phusewiki.org.. Modified disease activity score that include 28 joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. 2012.

12. Prevoo, ML, Vant Hof, MA, Kuper, HH, Van leeuwen, MA, Vande Puttel, B, Van Riel, PL. Modified disease activity score that include twenty eight joint counts. Development and valditatoin in a prospective study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1): 44-48.

13. Majithia, V, Geraci, SA. Rheumatoid Arthritis: Diagnosis and Management. Am. J. Med. 2007; 120(11): 936-9.

14. Balsa A, Pascual-Salcedo, D, Tinture, T, et al."Clinical characteristics of familiar rheumatoid

arthritis in Spain. A study of 73 families. J Rheumatol . 2005; 22 : 2020-6 .

15. Goldsby, RA, Kindt, TJ & Oaborne, BA. "Autoimmunity" In: Kuby Immunology, 4th ed . Freeman. W.H.& Company, NY;2000:497-516. 16. Bruun, J.M, Pedersen, S.B, Kristensen, K, Richelsen, B. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol. 2002; 190: 91–99 17. Sarraf, P, Frederich, R.C, Turner, E.M , Ma, G, Jaskowiak, N.T, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 1997;185: 171–175 18. Krysiak, R, Handzlik-Orlik, G, Okopien, B. The role of adipokines in connective tissue diseases. Eur J Nutr. 2012; 51(5): 513–528 19. Seven, A, Guzel, S, Aslan, M, Hamuryudan, V. Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int. 2009; 29: 743–747 20. Wislowska, M, Rok M, Jaszczyk, B, Stdpiej, K, Cicha, M. Serum leptin in rheumatoid arthritis. Rheumatol Int. 2007; 27: 947–954. 21. Dunn, OJ, Clark, VA. 2009. Basic statistics a primer for the biomedical sciences. 4th ed. John Wily and Sons, New Jersey. pp: 41-146.